GLP-1R Activators

GLP-1R activators are a class of molecules that target and activate the glucagon-like peptide-1 receptor (GLP-1R). The glucagon-like peptide-1 receptor is a G protein-coupled receptor (GPCR) that predominantly resides on the surface of beta cells in the pancreas. Activation of this receptor leads to various intracellular signaling cascades that modulate several physiological processes, especially in the realm of glucose homeostasis. The natural ligand for this receptor is the glucagon-like peptide-1 (GLP-1), an incretin hormone secreted from the intestinal L cells in response to nutrient ingestion. Once released, GLP-1 binds to its receptor, initiating actions that contribute to the regulation of blood glucose levels.

Structurally, GLP-1R activators can be grouped into two main categories: peptide-based and small molecule-based activators. The peptide-based activators are often analogs or derivatives of the native GLP-1 hormone. Their structural modifications are typically aimed at increasing their stability and half-life, as native GLP-1 is rapidly degraded by the enzyme dipeptidyl peptidase-4 (DPP-4) in the circulation. On the other hand, small molecule activators are non-peptidic compounds that can stimulate the GLP-1R. The development of small molecule activators has been challenging due to the intricate and large binding pocket of the GLP-1R, which is typically better suited for peptide ligands.